Gallium-68-labeled radiopharmaceuticals: a review
Chemical Society Reviews · 2025 · 54 (16) · 7421-7483
DOI: 10.1039/d5cs00392j ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Chemical Society Reviews, 2025. Verfasst von Karan S Tanwar und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nuclear Medicine, Department of Radiology, Mayo Clinic, 200 First Street SW, Rochester, MN-55905, USA. pandey.mukesh@mayo.edu. Hauptthemen laut MEDLINE: Gallium Radioisotopes, Radiopharmaceuticals. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 377 Literaturangaben. Gefördert von: Union for International Cancer Control.
Abstract (Originalsprache)
This review delves into the realm of gallium-68 ( 68 Ga)-labeled radiopharmaceuticals.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Nuclear Medicine, Department of Radiology, Mayo Clinic, 200 First Street SW, Rochester, MN-55905, USA. pandey.mukesh@mayo.edu.
- Post Graduate Institute of Medical Education and Research, Chandigarh-160012, India.
- Mayo Clinic Comprehensive Cancer Center, Rochester, MN-55905, USA.
- Department of Pharmacology, Mayo Clinic, Rochester, MN-55905, USA.
Förderung
- Union for International Cancer Control
Zitieren
APA
Tanwar, K. S., & Pandey, M. K. (2025). Gallium-68-labeled radiopharmaceuticals: a review. Chemical Society Reviews, 54(16), 7421-7483. https://doi.org/10.1039/d5cs00392j
Vancouver
Tanwar KS, Pandey MK. Gallium-68-labeled radiopharmaceuticals: a review. Chemical Society Reviews. 2025;54(16):7421-7483. doi:10.1039/d5cs00392j
BibTeX
@article{Tanwar2025,
author = {Tanwar, Karan S and Pandey, Mukesh K},
title = {Gallium-68-labeled radiopharmaceuticals: a review},
journal = {Chemical Society Reviews},
year = {2025},
volume = {54},
number = {16},
pages = {7421--7483},
doi = {10.1039/d5cs00392j}
}
EUVIMED